ArticleNaunyn-Schmiedeberg's archives of pharmacology2005

The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.

Susanne Horner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.